Cardiac Effects of Fixed-dose Dual Bronchodilator in Patients With Heart Insufficiency and COPD
Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the pulmonary and cardiac effects of a LABA / LAMA
combination therapy in patients suffering from both chronic heart failure and chronic
obstructive pulmonary disease.
The secondary aim of the study it to assess the safety of the LABA / LAMA combination.